Get a quote

Get a free quote now.

Thank you! Your message has been received!
Oops! Something went wrong while submitting the form.

Deciding Between Vancomycin AUC Monitoring Approaches

InsightRX
March 26, 2020

In a previous post, we covered why the new consensus guidelines on therapeutic monitoring of vancomycin have the potential to improve patient safety by reducing rates of acute kidney injury (AKI). We’ve also reviewed the clinical and technical considerations of the 2-level approach using first-order pharmacokinetic (PK) equations and Bayesian-derived approaches to vancomycin AUC-monitoring.

If your hospital or health system is committed to adopting AUC monitoring to guide vancomycin dosing as recommended by the new consensus guidelines, you’re likely trying to decide between these two approaches. To help you make an informed decision, we’ve summarized the tradeoffs in this infographic.

Fill out the form below to download the infographic.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Recent news